INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
2,531,968
Share change
+294,654
Total reported value
$64,270,000
Price per share
$25.43
Number of holders
16
Value change
+$7,492,708
Number of buys
9
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q4 2019

As of 31 Dec 2019, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,531,968 shares. The largest 10 holders included NEW YORK LIFE INVESTMENT MANAGEMENT LLC, MACKAY SHIELDS LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, Centric Wealth Management, JANE STREET GROUP, LLC, RBA Wealth Management, LLC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, and BANK OF AMERICA CORP /DE/. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.